02.13.2017 Secondary Announcement
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Aldeyra Therapeutics Inc. Symbol: ALDX Price: Last trade $4.75 Description: Re-offer $4.50 Trade Date: 2/14 Shares: 2.2 million Underwriter(s)Stifel, Canaccord Genuity,[…]
